Loading...
Schedule-dependent therapeutic efficacy of L19mTNF-α and melphalan combined with gemcitabine
L19-tumor necrosis factor alpha (L19mTNF-α; L), a fusion protein consisting of mouse TNFα and the human antibody fragment L19 directed to the extra domain-B (ED-B) of fibronectin, is able to selectively target tumor vasculature and to exert a long-lasting therapeutic activity in combination with mel...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Blackwell Science Inc
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3799282/ https://ncbi.nlm.nih.gov/pubmed/24156020 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.89 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|